AI assistant
ROOLIFE GROUP LTD — Capital/Financing Update 2016
Nov 14, 2016
65712_rns_2016-11-14_3e61264b-40c6-468b-84df-7ef4d1ee154b.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Notice
Notice reference number: # 1356.16.11
Notice date: 15/11/2016
What’s this about?
Effective date: 16/11/2016
==> picture [475 x 91] intentionally omitted <==
----- Start of picture text -----
ASX Trade ASX 24 ASX TECH
Trading Clearing Settlement ALC ASX NET
Operations Technology Market Data Rules Compliance Risk Other
----- End of picture text -----
Title
OpenDNA Limited – Admission and Commencement of Official Quotation
Description
OpenDNA Limited (“Company”) was admitted to the Official List of ASX Limited (“ASX”) on Tuesday 15 November 2016.
Official quotation of the Company’s securities will commence at 1:30pm AEDT (10:30am WST) on Wednesday, 16 November 2016.
The Company raised $8 million pursuant to the offer under the replacement prospectus dated 6 October 2016 (“Prospectus”) by the issue of 40,000,000 fully paid ordinary shares (“Shares”) at an issue price of $0.20 per Share.
Quoted Securities: 47,800,010 fully paid ordinary shares ASX Code: OPN Time: 1:30 PM AEDT (10:30 AM WST) Date: Wednesday 16 November 2016 ASX Trade Abbreviation: OPENDNA ISIN: AU000000OPN5 Home Branch: Perth Industry Classification: TBA Registered Office: Suite 8, 7 The Esplanade Mt Pleasant WA 6153 Company Secretary: Kevin Hart Share Registry: Computershare Investor Services Pty Ltd Level 11, 172 St Georges Terrace Perth, WA 6000 Ph: +61 8 9323 2000 Fax: +61 8 9323 2033 Balance Date: 30 June
CHESS: Participating. The Company will also operate an issuer sponsored sub‐register.
1/2
(continued)
ASX Notice
Place of Incorporation: Western Australia Dividend Policy: See page 14 of the replacement prospectus dated 6 October 2016 for further details. Activities: Development and commercialisation of digital analytics technology. Lead Manager Argonaut Securities ASX Restricted Securities: 42,482,621 fully paid ordinary shares, classified by ASX as restricted securities and to be held in escrow for a period of 24 months from reinstatement to official quotation.
5,450,000 options exercisable at $0.30 each on or before 9 September 2019 classified by ASX as restricted securities and to be held in escrow for a period of 24 months from reinstatement to official quotation.
4,150,000 options exercisable at $0.35 each on or before 30 June 2021 classified by ASX as restricted securities and to be held in escrow for a period of 24 months from reinstatement to official quotation.
4,150,000 options exercisable at $0.40 each on or before 30 June 2023 classified by ASX as restricted securities and to be held in escrow for a period of 24 months from reinstatement to official quotation.
2,000,000 options exercisable at $0.30 each on or before 11 November 2020 classified by ASX as restricted securities and to be held in escrow for a period of 24 months from reinstatement to official quotation.
35,000,000 performance shares, classified by ASX as restricted securities and to be held in escrow for a period of 24 months from reinstatement to official quotation.
14,800,909 fully paid ordinary shares, classified by ASX as restricted securities and to be held in escrow until 9 September 2017.
What do I need to do and by when?
Instructions
Please refer to the replacement prospectus and the Company’s website for further information.
Need more information? Issued by Contact Details Wade Baggott (08) 9224 0000
2/2